Article | Open

A general reaction mechanism for carbapenem hydrolysis by mononuclear and binuclear metallo-β-lactamases

  • Nature Communications 8, Article number: 538 (2017)
  • doi:10.1038/s41467-017-00601-9
  • Download Citation
Published online:


Carbapenem-resistant Enterobacteriaceae threaten human health, since carbapenems are last resort drugs for infections by such organisms. Metallo-β-lactamases (MβLs) are the main mechanism of resistance against carbapenems. Clinically approved inhibitors of MBLs are currently unavailable as design has been limited by the incomplete knowledge of their mechanism. Here, we report a biochemical and biophysical study of carbapenem hydrolysis by the B1 enzymes NDM-1 and BcII in the bi-Zn(II) form, the mono-Zn(II) B2 Sfh-I and the mono-Zn(II) B3 GOB-18. These MβLs hydrolyse carbapenems via a similar mechanism, with accumulation of the same anionic intermediates. We characterize the Michaelis complex formed by mono-Zn(II) enzymes, and we identify all intermediate species, enabling us to propose a chemical mechanism for mono and binuclear MβLs. This common mechanism open avenues for rationally designed inhibitors of all MβLs, notwithstanding the profound differences between these enzymes’ active site structure, β-lactam specificity and metal content.


Carbapenems are “last resort” drugs for treating infections from multi-resistant Gram-negative pathogenic bacteria1,2,3. Their action is continuously challenged by the emergence and spread of new resistance mechanisms4, 5. As a consequence, infections caused by resistant microorganisms fail to respond standard treatments, resulting in prolonged illness and greater risk of death2. Carbapenem-resistant Gram-negative bacteria are rapidly emerging as a cause of opportunistic healthcare-associated infections, with high mortality rates6. This situation has led to a “global crisis” of antibiotics that is exacerbated by the lack of novel agents effective against these pathogens2.

Resistance to carbapenems in Gram-negative bacteria is mostly due to the production of carbapenemases (carbapenem-hydrolysing β-lactamases). Metallo-β-lactamases (MβLs) are one of the largest and most efficient family of carbapenemases7,8,9,10. These enzymes employ Zn(II) as an essential cofactor to cleave the β-lactam ring and inactivate these antibacterial agents7, 10. Most MβLs are broad-spectrum enzymes that also hydrolyse penicillins and cephalosporins. These facts, together with the worldwide dissemination of MβL-encoding genes, raise an alarming clinical problem8. In particular, the gene coding for the NDM-1 MβL has rapidly spread worldwide, not only in clinical settings but also in the environment11, 12. Inhibitors developed for the serine-β-lactamases are not effective against MβLs, and specific inhibitors for MβLs are not yet available for clinical use7, 9, 10.

The design of an efficient MβL inhibitor has been limited by the structural diversity of the different members of this enzyme family7. MβLs are classified into three different subclasses: B1, B2, and B3, which differ in their active site structures, zinc stoichiometry, loop architectures, and substrate profiles7. Most MβLs possess a binuclear active site in which two Zn(II) ions (Zn1 and Zn2) are bridged by a hydroxide (Fig. 1). This stoichiometry is found in B1 and in most B3 enzymes, in which Zn1 is tetrahedrally coordinated to three histidine ligands (3 H site) and the bridging hydroxide13,14,15,16. However, the ligand set of Zn2 differs: in B1 enzymes it is provided by residues Asp120, Cys221, and His263 (DCH site)14, while in B3 MβLs it involves residues Asp120, His121, and His263 (DHH site)15; in both cases the ligand set is completed by one or two water molecules. Notably, in B2 and in some B3 enzymes, residue His116 is replaced by less common and weaker metal binding ligands, such as Asn or Gln, respectively, giving rise to active mono-Zn(II) MβLs with the metal ion located in the Zn2 site16,17,18. These mononuclear enzymes display further functional and structural diversity: B2 enzymes only hydrolyse carbapenems17 and display a DCH-like Zn2 site17, while the B3 MβL GOB-18 from Elizabethkingia meningoseptica is a broad-spectrum enzyme which is active as a bi-Zn(II) or as a mono-Zn(II) enzyme with the metal ion bound to the canonical Zn2 (DHH) site present in binuclear B3 enzymes (Fig. 1)16, 19.

Fig. 1
Fig. 1

Active sites of metallo-β-lactamases. Klebsiella pneumoniae bi-Zn(II)-NDM-1 (B1, PDB 3spu, left), Serratia fonticola mono-Zn(II)-Sfh-I (B2, PDB 3sd9, center) and E. meningoseptica mono-Zn(II)-GOB-18 (B3, model based on PDB 5k0w, right). Zinc atoms are shown as grey spheres, and water molecules (W) are shown as small red spheres. Coordination bonds are indicated with dashed lines

This structural diversity has led to different mechanistic proposals10, which mostly have involved a controversy about: (1) the essentiality of the different Zn(II) sites20,21,22,23; (2) the identity of the nucleophile, which has been proposed to be the Zn1-bound hydroxide in bi-Zn(II) enzymes based on biochemical evidence22, 24, 25, but has not been identified in mononuclear variants; (3) the identity of the proton donor to the β-lactam amide nitrogen; (4) the substrate binding mode26, 27, and (5) the identification of mechanistic intermediates28. In this last regard, nitrocefin and other chromogenic cephalosporins have been useful as mechanistic probes to identify reaction intermediates29, 30. However, these intermediates were not detected in all cases analysed31. Furthermore, since B2 enzymes are exclusive carbapenemases, these MβLs cannot be effectively interrogated using these compounds. Indeed, carbapenems are the only substrates common to all MβLs7.

Structures of enzyme-product complexes of B1 and B3 enzymes with hydrolysed carbapenems have been reported, providing structural insight into the mechanism32,33,34, but the detection of reaction intermediates in carbapenem hydrolysis has been challenging due to the limited spectroscopic properties of these compounds. Based on a previous work in the model enzyme BcII from Bacillus cereus28, we decided to interrogate a series of MβLs by a combined approach using rapid-mixing techniques coupled to a range of spectroscopies to compare the mechanistic differences across MβL subclasses with different active sites and metal stoichiometries. Notably, all MβLs hydrolyse carbapenems via a similar branched catalytic mechanism that involves accumulation of two productive anionic intermediates. The proposed structures for these intermediates allow us to suggest the proton donors in this mechanism. Mono-Zn(II) enzymes additionally reveal accumulation of the Michaelis complex, in contrast to bi-Zn(II) MβLs. We attribute this difference to the involvement of a metal-activated nucleophile in binuclear enzymes, which accelerates the first chemical step of the reaction; thereby suggesting that nucleophile activation in mono-Zn(II) enzymes does not involve the metal site. These findings suggest that design strategies for inhibitors active against the full range of MβLs should be based upon these common mechanistic features, overcoming the challenge posed by the structural diversity of these enzymes.


Imipenem hydrolysis by a mono-Zn(II) B3 MβL

The presence of two metal ions in binuclear MβLs complicates spectroscopic studies as the individual signatures of the two metal sites overlap. Thus, we initially studied mono-Zn(II) enzymes. Subclass B3 GOB enzymes have a Gln residue at position 116, replacing the usual His ligand, and thus impairing metal binding at the Zn1 site (Fig. 1). This enzyme can be active either as a bi-Zn(II) or as a mononuclear enzyme with the metal ion located in the Zn2 (DHH) site16, 19. We studied imipenem hydrolysis catalysed by mono-Zn(II)-GOB-18 under pre-steady-state conditions using a photodiode-array detector coupled to a stopped-flow device.

Substrate consumption during hydrolysis was monitored following absorbance at 300 nm (Abs300nm). Progress curves showed a lag phase followed by a triphasic decrease in Abs300nm (Supplementary Fig. 1a). Time-resolved spectra corresponding to the full duration of the reaction were then acquired. Difference spectra showed accumulation of a species absorbing at 340 nm during the first fast phase (Fig. 2a, Supplementary Fig. 1 and Supplementary Table 1), suggesting the presence of a reaction intermediate absorbing at this wavelength. The progress curves could not be fit to any simple linear kinetic model (Supplementary Fig. 2a–f). Instead, the minimal kinetic scheme that accounted for the kinetic traces at both wavelengths required a branched pathway involving two productive intermediate species (EI1 and EI2), where EI2 is the species absorbing at 340 nm in the difference spectra (Fig. 3 and Supplementary Fig. 2g–i).

Fig. 2
Fig. 2

Electronic absorption spectra of imipenem hydrolysis catalysed by mononuclear MβLs. a Sequence of difference spectra upon the reaction of 91 μM imipenem and 51.4 μM Zn(II)-GOB-18. The reaction progresses from yellow to green spectra. The time interval covers up to 50 s. b Sequence of difference spectra upon the reaction of 3.5 mM imipenem and 430 μM mono-Co(II)-GOB-18. The reaction progresses from blue to pink spectra. The time interval covers from 14.7 to 26.6 s. The inset shows a magnification of the 450–700 nm region. c Sequence of difference spectra upon the reaction of 3 mM imipenem and 350 μM mono-Zn(II)-Sfh-I. The reaction progresses from red to grey spectra. The time interval covers up to 50 s

Fig. 3
Fig. 3

General reaction mechanism for carbapenem hydrolysis by MβLs. The ES complex does not accumulate in all cases and is hence depicted in a lighter colour (grey)

Simulation of the time evolution of the different species in the reaction, based on the kinetic parameters of this branched model, reveals significant population of the Michaelis complex (ES) prior to accumulation of EI2 (Supplementary Fig. 3a). The simulation further reveals accumulation of EI2 in greater amounts than EI1, in agreement with the lack of a direct observation of the absorption features of EI1. Thus we next designed different experiments to characterize ES and EI2, exploiting the different time frames of their maximal accumulation.

The Michaelis complex was characterized by rapid-freeze-quench mixing experiments coupled to X-ray absorption spectroscopy, which allows for monitoring of the coordination sphere of the metal site. We studied mono-Zn(II)-GOB-18 in the resting state, a mixture of this enzyme and imipenem after 10 ms of reaction (where ES is predicted to be the major species), and the final enzyme-product (EP) complex (Supplementary Fig. 3b). The Zn K-edge spectrum for mono-Zn(II)-GOB-18 in the resting state19 showed a first coordination shell of 4 N/O at a mean distance of 2.01 Å (including 2 His ligands; Table 1), consistent with the coordination sphere of the Zn2 centre observed by X-ray crystallography (Fig. 1)16. After 10 ms of reaction with imipenem, the average Zn−N/O bond length increased to 2.07 Å, with the increase in distance being consistent with a larger coordination number in the enzyme-substrate complex (Table 1, Supplementary Fig. 4a and Supplementary Table 2). The first shell bond length in the product complex remained substantially longer than in the resting enzyme at 2.08 Å (Table 1, Supplementary Fig. 4b and Supplementary Table 2), suggesting that the Zn(II) ion progressed from four-coordinate in the resting state to five-coordinate in the Michaelis (ES) and product (EP) complexes. The XANES spectra (Supplementary Fig. 5) showed a dramatic increase in the white line intensity that was retained in the product complex, which was consistent with an increase in the coordination number in both ES and EP. Based on fits to the EXAFS data, we suggest this represents incorporation of the C-3 carboxylate as a ligand of Zn2, with retention of the metal-bound water molecule present in the resting state enzyme.

Table 1: Representative EXAFS fits for mono-Zn(II)-GOB-18, mono-Zn(II)-Sfh-I and bi-Zn(II)-BcII

We performed the hydrolysis reaction under conditions in which the accumulation of EI2 is maximized. The difference spectrum recorded by the photodiode array at 600 ms displayed the absorption band of EI2 (Supplementary Fig. 3c). These features confirm the presence of a reaction intermediate but do not provide structural information. To better characterize EI2, we then studied mono-Co(II)-GOB-18. This species is active against imipenem, with similar KM but ten-fold smaller kcat values compared to mono-Zn(II)-GOB-1819, 35. The lower catalytic efficiency of the Co(II) derivative (Supplementary Table 3) and the rich spectroscopic features of the Co(II) ion, provide an opportunity to monitor changes in the metal coordination sphere during turnover and to determine the individual rate constants for formation/disappearance of intermediate species. Resting state mono-Co(II)-GOB-18 is pentacoordinate, according to the ligand field bands in the visible range35. After rapid mixing of imipenem and mono-Co(II)-GOB-18, time-resolved spectra showed these ligand field bands to disappear and give rise to new features, indicating that changes occurred in the coordination geometry of the Co(II) site (Fig. 2b and Supplementary Fig. 6). Later, an intense absorption band developed at 340 nm whose subsequent decay was coincident with a recovery of the ligand field features of resting mono-Co(II)-GOB-18, as evidenced by well-defined isosbestic points (Fig. 2b, Supplementary Fig. 6e and Supplementary Table 1). Kinetic traces monitoring reaction at 300 nm (reporting on substrate-bound (ES) and intermediate species), 340 nm (intermediate species), and 635 nm (ligand field bands of the Co(II) ion in the resting enzyme) at different enzyme:substrate ratios fitted to a mechanism with two productive reaction intermediates, similar to mono-Zn(II) GOB-18 (Supplementary Fig. 7). In this mechanism, the absorption peak at 340 nm can also be attributed to EI2. The smaller molar extinction coefficients at 635 nm estimated for the ES and EI complexes, compared to the values for the resting state enzyme (E), suggest an increase in the coordination number upon substrate binding and during turnover36, in agreement with the EXAFS data for the Zn(II)-enzyme (Table 1). Recovery of the ligand field bands to intensities observed for the resting enzyme took place after consumption of this intermediate. We conclude that the metal ion in Co(II)-GOB is hexacoordinated in ES, EI1, and EI2. Thus, catalysis by mono-Zn(II) and Co(II)-GOB follow the same reaction mechanism, with expansion of the coordination number during turnover, differing only by the presence of an additional water molecule in the Co(II) variant.

Imipenem hydrolysis by a mono-Zn(II) B2 MβL

We next applied similar approaches to study imipenem hydrolysis by the mono-Zn(II) B2 lactamase Sfh-I. Transient peaks in absorbance spectra of the complete reaction time course obtained by stopped-flow absorption spectroscopy revealed accumulation of two species. First, a species with a maximum at 390 nm decayed during the early phases of the reaction and next, the absorbance at 340 nm increased and then decreased (Fig. 2c, Supplementary Fig. 8 and Supplementary Table 1). The latter resembles the spectral features observed for EI2 during the hydrolysis of imipenem by mono-Zn(II)-GOB-18 (Fig. 2a), allowing us to conclude that the species absorbing at 390 nm may correspond to intermediate EI1 that was derived from the fitting but could not be observed in the case of mono-Zn(II)-GOB-18.

In order to better characterize these two intermediates, we carried out a series of experiments at lower concentrations of mono-Zn(II)-Sfh-I and imipenem, with the aim of reducing the hydrolysis rate. Although the low signal-to-noise ratio at 390 nm precluded monitoring of EI1 during the reaction, traces were recorded at 300 and 340 nm and analysed by simultaneous global fitting. We could not fit these data to any linear mechanism involving both intermediates. Instead, these data could be accounted for by assuming the same branched mechanism employed for mono-Zn(II)-GOB-18 (Fig. 3 and Supplementary Fig. 9). Thus, despite having different metal sites, mono-Zn(II)-GOB-18 and mono-Zn(II)-Sfh-I follow the same kinetic mechanism for imipenem hydrolysis. This, together with the similar absorbance properties of the EI2 species identified for each reaction, suggests that imipenem hydrolysis by the two enzymes occurs by the same mechanism and involves the same two reaction intermediates. Simulation of the different species during hydrolysis (Supplementary Fig. 10) confirms a significant accumulation of EI1, allowing us to assign the spectral features at 390 nm to this species.

We then monitored the reaction of mono-Zn(II)-Sfh-I with imipenem using X-ray absorption spectroscopy. The XANES spectra for mono-Zn(II)-Sfh-I in the resting state, 10 ms after mixture with imipenem (when ES is the predominant enzyme species) and in the enzyme-product complex were nearly superimposable (Supplementary Fig. 5), indicating a lack of appreciable rearrangement at the metal site over the course of the reaction. This result is supported by a comparison of the EXAFS Fourier transforms (Table 1, Supplementary Fig. 11 and Supplementary Table 4). The only appreciable differences are a slight enhancement of the Zn−S scattering in the first shell of the 10-ms sample, and some complex outer shell contributions at 10-ms that disappear in the product complex, indicative of interaction with the substrate. This observation indicates that different metal site geometries can stabilise similar reaction intermediates (such as those evidenced by absorption spectroscopy).

Carbapenem hydrolysis by bi-Zn(II) B1 MβLs

Hydrolysis of imipenem by bi-Zn(II)-NDM-1 under single turnover conditions revealed an increase of absorbance at 390 nm during the first 2 ms of the reaction, that then decays as another species accumulates with an absorption at 343 nm (Fig. 4a, Supplementary Fig. 12 and Supplementary Table 1). These spectral features can be attributed to the two reaction intermediates, EI1 and EI2, respectively, based on the similarities of their spectral features with those observed for mono-Zn(II)-Sfh-I (Fig. 2c). Since the band at higher energy (343 nm) partially overlaps with the absorption of imipenem, we fitted the time evolution of the absorption traces at 390 nm and 300 nm at different enzyme:substrate ratios. These data could be fitted to a mechanism with two productive intermediates (Fig. 3 and Supplementary Fig. 13), similar to that proposed for the two mono-Zn(II) enzymes described above. In contrast to the case for the mono-Zn(II) enzymes, the best fit was obtained when the Michaelis complex ES was omitted from the model (Supplementary Figs. 13, 14). Our data suggested that in this case formation and decay of ES occurred in the dead time of the equipment (2 ms) under all tested conditions. We also assayed hydrolysis of another carbapenem, meropenem, by bi-Zn(II)-NDM-1, and observed accumulation of two similar reaction intermediates with absorption bands at 375 nm (EI1) and 336 nm (EI2), respectively (Fig. 4b, Supplementary Fig. 15 and Supplementary Table 1). Overall, these results show that binuclear B1 MβLs hydrolyse carbapenems by the same branched mechanism as that described for the mono-Zn(II) enzymes.

Fig. 4
Fig. 4

Electronic absorption spectra of carbapenem hydrolysis catalysed by binuclear MβLs. a Sequence of difference spectra upon the reaction of 150 μM imipenem and 95 μM bi-Zn(II)-NDM-1. The reaction progresses from orange to blue spectra. The time interval covers from 0.002 to 0.07 s. b Sequence of difference spectra upon the reaction of 100 µM meropenem and 100 μM bi-Zn(II)-NDM-1. The reaction progresses from blue to black spectra. The time interval covers from 0.002 to 0.05 s. c Sequence of difference spectra upon the reaction of 450 µM imipenem and 112.5 μM bi-Co(II)-NDM-1. The reaction progresses from green to purple spectra. The time interval covers from 0.002 to 0.67 s. The inset shows a magnification of the 450–720 nm region

To obtain further information on the nature of intermediates populated during carbapenem hydrolysis by binuclear MβLs, these experiments were extended to bi-Co(II)-NDM-1, which has a similar catalytic performance (Supplementary Table 3). Analysis of the hydrolysis of imipenem by bi-Co(II)-NDM-137 revealed formation of an intermediate species with a strong absorption band at 412 nm, matching the spectroscopic features previously reported for the hydrolysis of imipenem by bi-Co(II)-BcII (Fig. 4c, Supplementary Fig. 16 and Supplementary Table 1)28. The characteristic ligand field bands of the Co(II) ion in the resting enzyme (450–700 nm) disappeared upon the reaction with imipenem, giving rise to new spectral features and revealing that changes occurred in the geometry of the Co(II) sites (Fig. 4c and Supplementary Fig. 16). The time courses of the absorption at 412 (the intermediate maximum), 567 and 642 nm (d–d bands) at three different enzyme:substrate ratios were measured and fitted to different kinetic models. The progression of the intensities at 567 nm and 412 nm showed an initial increase in intensity followed by a decrease, and these features were assigned to EI1. The best fits to the data were obtained using the branched mechanism involving two productive intermediates proposed for bi-Zn(II)-NDM-1 (Supplementary Fig. 17). The extinction coefficients attributed to the ligand field bands for EI1 and EI2 reveal that the metal sites in these intermediates have similar coordination geometries (Supplementary Fig. 17), both with higher coordination numbers than in the resting state enzyme.

We then used X-ray absorption spectroscopy to analyse hydrolysis of imipenem by the B1 enzyme bi-Zn(II)-BcII. While XAS of binuclear enzymes cannot resolve the features of individual metal sites, it provides average metal site structure, and valuable information about the Zn–Zn distance during turnover. The EXAFS of resting bi-Zn(II)-BcII (previously reported) could be fitted with an average first shell of 4 N/O and 0.5 S, including 2 His ligands per Zn(II), and a Zn–Zn separation of 3.42 Å38. After 10 ms of reaction with imipenem, the first shell peak in the FT diminished and broadened, being best fit with 4.5 N/O + 0.5 S per Zn(II) ion (Table 1, Supplementary Fig. 18a and Supplementary Table 5), indicating a small increase in average coordination number, and a Zn−Zn distance of 3.82 Å. The corresponding EP complex of bi-Zn(II) BcII and imipenem was best fitted with similar parameters, but a substantially shorter Zn–Zn distance of 3.51 Å (Table 1, Supplementary Fig. 18b and Supplementary Table 5). Thus, changes in the coordination geometry of the metal site are accompanied by a significant lengthening of the Zn–Zn distance in the formed intermediates.

Identity of the reaction intermediates

The last step in the enzyme-catalysed hydrolysis of carbapenems is expected to be the protonation of the N atom9, giving rise to the Δ2 tautomer, that later equilibrates in solution to generate the more stable Δ1 tautomer with a 1:1 ratio of the α and β diastereomers (Fig. 5)39. To investigate sites of protonation in MβL-catalysed carbapenem hydrolysis, we determined the α:β diastereomer ratio for the imipenem hydrolysis products of the GOB-18, Sfh-I and NDM-1 enzymes by 1H-NMR spectroscopy39. These experiments yielded values ranging between 1:5 and 1:7, i.e., with the β diastereomer in substantial excess, in contrast to the acid-induced hydrolysis (Fig. 5c). This ratio can be accounted for only by assuming that, in addition to protonation at the N atom, a diastereoselective protonation at C-2 takes place within the enzyme active site, whose product is the Δ1β diastereomer. Since our kinetic schemes include two productive intermediates (EI1 and EI2), we envisioned that these intermediates could present chemical differences that would favour either protonation at N or at C-2 (Fig. 5b).

Fig. 5
Fig. 5

Analysis of the population of tautomers in the MβL-catalysed imipenem hydrolysis. a Structure and atom numbering of imipenem. b Tautomeric structures of hydrolysed imipenem. c 1H-NMR spectra of the products of imipenem hydrolysis by mono-Zn(II)-GOB-18 (blue), mono-Zn(II)-Sfh-I (red), bi-Zn(II)-NDM-1 (yellow), and HCl (black). In all cases only tautomer Δ1 was detected. Signal assignments are indicated on top and were taken from Ratcliffe et al.39. The α:β diastereomer ratio is indicated on the left

In an effort to generate structural models for possible enzyme-bound intermediates, we inspected the available crystal structures for enzyme-product complexes of bi-Zn(II) NDM-1 with carbapenems (pdb coordinates 4eyl32 and 4rbs). Both structures lack a metal-bound hydroxide, which would be expected to be present following N protonation by a metal-bound water molecule (Supplementary Fig. 19). The absence of a metal-bound hydroxide in the EP complexes could be instead due to C-2 protonation within the enzyme, which would then be elicited by water molecules present at other locations within the active site. We used QM-MM calculations to analyse the stability of anionic species that could give rise to these EP complexes. Simulations starting from anionic species generated from 4eyl32 and 4rbs converged to similar Zn(II) coordination geometries (Fig. 6a, EI), with shorter N−Zn2 distances than those observed in the EP crystal structures (Supplementary Table 6), consistent with the anionic nature of the intermediates. The C-7 carboxylate resulting from β-lactam cleavage bridges the two Zn(II) ions (Fig. 6a). The C2–C3 and C3–N distances of the minimized structures correspond to bond lengths intermediate between single and double bonds in both cases, suggesting a delocalized anionic structure for EI. This observation is in agreement with a previous RFQ-Resonance Raman characterization of a reaction intermediate in imipenem hydrolysis by bi-Co(II)-BcII that revealed a vibrational feature with a frequency intermediate between those of single and double bonds28.

Fig. 6
Fig. 6

Structure of the proposed intermediate species formed during the hydrolysis of carbapenems by bi-Zn(II)-MβLs. Optimized structures of EI a and EIWAT b. The quantum protein subsystem is depicted with the conventional liquorice colours (C cyan, H white, O red, N blue, and S yellow). Zn(II) ions are shown as grey spheres. Carbon atoms of the antibiotic derived ligand are shown in orange. Coordination bonds of the amino acid residues to Zn(II) are shown with solid lines and interactions with the antibiotic derived ligand are shown with dotted lines

We also explored anionic intermediates in alternative structures containing a Zn(II)-bound water molecule, as would be expected for a mechanism involving N protonation. The minimized structures (EIWAT, Fig. 6b) also featured a short N–Zn2 bond, with the extra water molecule bridging the two Zn(II) ions. Instead, the C-7 carboxylate moiety was found to bind Zn1 only (Fig. 6b and Supplementary Fig. 20). Minimized geometries for EIWAT also feature delocalized single and double bonds between C2–C3 and C3–N.

Both EI and EIWAT feature a large charge delocalization onto the unsaturated five-membered ring and the adjacent sulphur atom (Supplementary Table 7). As a consequence, both the N and the C-2 atoms bear small partial negative charges. Thus, specific N or C-2 protonation may not be driven by the charges residing on these atoms but, instead, by the availability of a proton donor. In EIWAT, N protonation by the bridging water is favoured (Fig. 6b), giving rise to the Δ2 tautomer. We thus explored the distribution of water molecules in the active site in EI looking for possible proton donors to C-2. Molecular dynamics simulations on EI revealed the presence of several water molecules between the hydrophilic loop L10 and the β face of the antibiotic (Supplementary Fig. 21), confirming the feasibility of diasteroselective C-2 protonation within the enzyme active site in this intermediate. Hence, we propose that the α:β diastereomer ratio in the product of carbapenem hydrolysis by MβLs is a consequence of the existence of two alternative protonation routes (N or C-2 protonation), determined by two reaction intermediates that differ in the identity and location of the proton donor. Thus, we assign structures EI and EIWAT to the observed reaction intermediates.

Minimization attempts on the EP complexes generated from these intermediates gave strikingly different results. The EP lacking the Zn(II)-bound water was stable upon geometry minimization, resembling the geometries of the reported crystal structures32, 33 (Supplementary Fig. 22 and Supplementary Table 8). In contrast, the EP with the Zn(II)-bound water was unstable in our calculations, resulting in a substantial lengthening of the Zn2–N and Zn1–COO distances, which may ultimately lead to product detachment from the active site. This is consistent with our kinetic data, which show that one of the productive intermediates, EI1, proceeds to product with no detectable accumulation of EP, while EI2 gives rise to stable EP complexes in all studied enzymes. Hence, we conclude that EI1 is EIWAT, undergoing N protonation and giving rise to the Δ2 tautomer; while EI2 is EI, which can be protonated at C-2 rendering the Δ1 β tautomer in the form of a stable EP complex (Fig. 6). The structures of the B3 lactamase SMB-1 with hydrolysed carbapenems show a Δ1 C-protonated tautomer from the β face, supporting this proposal34. Protonation of EI1 is faster than protonation of EI2 in all MβLs (Supplementary Table 9). The fact that N protonation by a metal-activated water molecule is expected to be faster, further supports the assignment of EI1 as EIWAT. Therefore, the two intermediates proceed to products through proton donors of distinct acidities which are located in different positions, and conversion of EI1 into EI2 involves dissociation of a water molecule from Zn2.


Based on these results, we propose detailed mechanistic models for the hydrolysis of carbapenems by binuclear and mononuclear MβLs (Fig. 7) consistent with a unified mechanistic scheme (Fig. 3). Despite their diverse active site structures, metal content and substrate spectrum, MβLs share a branched mechanism defined by the presence of two productive reaction intermediates (EI1 and EI2) with similar spectroscopic features. We also provide direct evidence of changes in the coordination geometry of the metal sites.

Fig. 7
Fig. 7

Proposed mechanisms for carbapenem hydrolysis by MβLs. a Proposed mechanism for mono-Zn(II)-MβLs. b Proposed mechanism for bi-Zn(II)-MβLs. The ES complex does not accumulate and is hence depicted in a lighter colour (grey). Its structure is proposed based on the ES detected for the mononuclear MβLs

In mono-Zn(II)-GOB, the presence of a single metal ion demonstrates the involvement of Zn2 in catalysis as changes in its geometry are evidenced upon formation of the Michaelis complex, and of intermediate EI2 (Fig. 7a). Substrate binding takes place by expansion of the coordination sphere of Zn2 in mono-Zn(II)-GOB-18, as revealed by XAS data and by the time evolution of the ligand field bands in the Co(II)-substituted enzyme. These observations are consistent with substrate binding to the metal ion through the carboxylate group at C-3, without dissociation of the metal-bound water molecule (ES in Fig. 7a). In contrast, the mono-Zn(II) B2 enzyme Sfh-I did not exhibit significant changes in its coordination geometry during turnover. In this case, it is likely that substrate binding takes place with dissociation of the metal-bound water, maintaining a tetrahedral coordination sphere.

In contrast to the case of mono-Zn(II) enzymes (Sfh-I and GOB-18), where the Michaelis complexes are detectable during the reaction, the concentration of the ES complex has already decayed within the dead time of the experiments with bi-Zn(II) enzymes. We propose that substrate binding in bi-Zn(II) enzymes takes place also by coordination of the carboxylate group at C-3 to Zn2, with detachment of the bridging hydroxide from this metal site, thus giving rise to a potent nucleophile (ES in Fig. 7b). A terminal hydroxide is expected to be a more efficient nucleophile than a bridging hydroxide, as it is also the case for other metallohydrolases. We thus favour the same hypothesis in this mechanism40.

The lack of accumulation of the Michaelis complex in the reaction catalysed by bi-Zn(II) enzymes reveals that the step involving the nucleophilic attack (ES → EI1) is faster in these enzymes compared to mono-Zn(II) species. The nucleophile in bi-Zn(II) MβLs is the hydroxide moiety bound to the Zn1 ion that is lacking in the mono-Zn(II) variants10, 22. Therefore, we conclude that mono-Zn(II) enzymes do not use a metal-activated nucleophile (Fig. 7a), supporting the proposal that a hydrogen bond network activates the nucleophilic water in mono-Zn(II) enzymes17, 41. QM-MM calculations and the kinetic data suggest that the two productive intermediates EI1 and EI2 correspond to EIWAT and EI, respectively (Fig. 6), both delocalized anionic species. The presence of a water molecule in EI1 leads us to conclude that, in binuclear enzymes, substrate binding takes place without replacement of the solvent molecule bound to Zn2 in the resting state, as observed in mononuclear GOB-18 (Fig. 7). This intermediate accumulates more in bi-Zn(II) enzymes (Fig. 4), while EI2 shows higher levels in mono-Zn(II) variants (Fig. 2). These results are consistent with the observation of reaction intermediates at 390 and 380 nm in SPM-142 and IMP-2543, that we are now able to assign to EI1. Other enzymes, such as mono-Zn(II) Bla2 did not show accumulation of any intermediate31.

Formation of intermediate species in bi-Zn(II)-BcII is accompanied by a significant lengthening of the Zn(II)–Zn(II) distance, which finally relaxes to an intermediate distance in the EP adduct. This behaviour resembles that reported for nitrocefin hydrolysis by the binuclear B3 enzyme L144, revealing similarities in the ways that MβLs with different active sites stabilise similar reaction intermediates on reaction with different substrates. The study of bi-Co(II)-NDM-1 indicates that, compared to the resting state enzyme, coordination geometry increases in EI1 and EI2. Rapid-freeze-quench EPR studies on bi-Co(II)-BcII and bi-Co(II) L1 have also revealed changes in the metal geometry in the intermediates28, 45. MCD spectroscopy could also be exploited with this goal46. In EI1, the deprotonated hydrolysed-carbapenem binds to Zn1 through the C-7 carboxylate and to Zn2 through the C-3 carboxylate and the N atom. In EI2, the carboxylate group at C-7 becomes a bridging ligand since it is also coordinated to Zn2 (Figs. 6, 7). The proposed coordination spheres of EI1 and EI2 in the mono-Zn(II) enzymes are equivalent to those proposed for Zn2 in bi-Zn(II) enzymes (Fig. 7a), further supporting the mechanistic resemblance to the atomic level.

Protonation at the nitrogen atom in EI1 elicits product formation and dissociation, restoring the active site configuration which, in the case of binuclear enzymes, involves the nucleophilic hydroxide (Fig. 7). Instead, protonation at C-2 in EI2 leads to accumulation of an EP complex lacking a metal-bound water molecule, in agreement with crystallographic evidence32, 33. Restoring the active site configuration takes place after product dissociation. All data here presented strongly support that EI2 undergoes a stereoselective protonation at C-2 involving a water molecule not bound to the metal site. This mechanistic scheme is fully consistent with all previous experimental evidence22, 23, 28, 29, 42, 43, 45. Finally, this mechanism highlights the difference between carbapenem and cephalosphorin hydrolysis. Hydrolysis of cephalosporins with poor leaving groups leads to C-protonation by the α face30.This observation is in line with a recent theoretical study suggesting a different proton donor in cephalosporin hydrolysis, that remains to be tested47. The identity of the distinct proton donors may be ultimately assessed by time-resolved crystallography studies.

The role and essentiality of the two Zn(II) ions in MβLs has been a matter of intense controversy22, 23, 31, 41, 48. Our study shows that MβLs from different subclasses and with distinct metal contents display a similar catalytic mechanism. This mechanism identifies Zn2 (present in mononuclear and binuclear MβLs, Fig. 1) as playing a central role in substrate binding26, in providing electrostatic stabilisation for the negative charge of two ring opened anionic intermediate species28, 29, and in activating the proton donor in one of the productive branches. These mechanistic results are in agreement with recent findings showing that B1 enzymes require a binuclear Zn(II) site in the periplasm to provide resistance23, and that improvements in the affinity for the Zn2 ion improve fitness49, 50. We propose two strategies for the first step involving the nucleophilic attack: a terminal hydroxide bound to the Zn1 ion in binuclear enzymes, or a water molecule activated by a hydrogen bond network in the mononuclear enzymes lacking Zn1, such as Sfh-I and GOB.

The rational design of a “pan-MβL inhibitor” effective against all such enzymes can be envisaged by exploiting these mechanistic features that are common across the full range of enzymes and are independent of the active site structures and metal content. We recently showed that a minimalistic scaffold mimicking a β-lactam substrate can be employed as an efficient inhibitor of MβLs from all subclasses51, 52. Efforts to design MβL inhibitors inspired in the chemical features of these common reaction intermediates are currently underway.


Protein production

Mono-Zn(II)-GOB-18 and bi-Zn(II)-BcII were expressed as N-terminal fusions to glutathione-S-transferase (GST) protein and purified by using an affinity column with a glutathione-agarose resin. GST was removed by treatment with bovine plasma thrombin (Sigma), and the lactamases were finally purified by ion exchange through a Sephadex CM-50 column13, 19. Mono-Zn(II)-Sfh-I was expressed in a pET-26b plasmid (Novagen) and purified by anion exchange (Q-Sepharose) and size exclusion (Superdex 75) chromatography17. Bi-Zn(II)-NDM-1 was expressed in a modified version of the pET-28 ( + ) plasmid in which the thrombin cleavage site was replaced by a TEV cleavage site51. The crude extract was loaded onto a Ni-Sepharose column, the obtained fusion protein was treated with TEV protease and the mixture was then loaded again onto a Ni-Sepharose column to obtain the pure cleaved protein51. All protein preparations have a purity > 95%, as determined by SDS-PAGE. Co(II) substituted enzymes were produced by adding CoSO4 to the apoenzymes, that were obtained by extensive dialysis against buffer (10 mM Hepes, pH 7.5, 200 mM NaCl) containing 20 mM EDTA and Chelex 10053.

Rapid kinetics experiments

The hydrolysis of imipenem catalysed by mono-Zn(II)-GOB-18, mono-Co(II)-GOB-18, mono-Zn(II)-Sfh-I, bi-Zn(II)-NDM-1, and bi-Co(II)-NDM-1 was followed employing a stopped-flow equipment (Applied Photophysics SX.18-MVR) coupled to a photodiode array. The pathlength was 1.0 cm and the integration time was 1.28 s. GOB-18 measurements were performed in 100 mM Hepes, pH 7.5, 200 mM NaCl, at 4 °C, and under pre-steady-state conditions. Measurements with mono-Zn(II)-Sfh-I were performed in 50 mM Hepes, pH 7,at 4 °C, and under pre-steady-state conditions. For NDM-1 the reaction buffer was 100 mM Hepes, pH 7.5, 200 mM NaCl and 300 µM ZnSO4 or 2 equivalents of CoSO4 in the case of bi-Co(II)-NDM-1, the reactions were performed at 6 °C and under pre-steady-state conditions.

Traces obtained at different wavelengths were subject to simultaneous global fit to different kinetic models using the software DynaFit54. The molar extinction coefficients employed for mono-Zn(II)-GOB-18 and mono-Co(II)-GOB-18 were: εE 300nm = 3900 M−1 cm−1 and εE 340nm = 670 M−1 cm−1 for the free enzyme, εS 300nm = 9360 M−1 cm−1 and εS 340nm = 410 M−1 cm−1 for the substrate, εES 300nm = 13,260 M−1 cm−1 and εES 340nm = 1080 M−1 cm−1 for the complex enzyme-substrate; ε EI1 300nm = 3900 M−1 cm−1 and ε EI1 340nm = 670 M−1 cm−1 for the complex enzyme-intermediate 1 (the same as the free enzyme); εEP 300nm = 4400 M−1 cm−1 and εEP 340nm = 825 M−1 cm−1 for the complex enzyme-product; and εP 300nm = 500 M−1 cm−1 and εP 340nm = 155 M−1 cm−1 for the product. The molar extinction coefficients employed for mono-Zn(II)-Sfh-I were: εE 300nm = 5600 M−1 cm−1 and εE 340nm = 350 M−1 cm−1; εS 300nm = 9360 M−1 cm−1 and εS 340nm = 410 M−1 cm−1; εES 300nm = 14,960 M−1 cm−1 and εES 340nm = 760 M−1 cm−1; εEI1 300nm = 5600 M−1 cm−1 and ε EI1 340nm = 350 M−1 cm−1 (the same as the free enzyme); εEP 300nm = 6100 M−1 cm−1 and εEP 340nm = 505 M−1 cm−1; and εP 300nm = 500 M−1 cm−1 and εP 340nm = 155 M−1 cm−1. The molar extinction coefficients employed for bi-Zn(II)-NDM-1 were: εE 300nm = 4937 M−1 cm−1 and εE 390nm = 46 M−1 cm−1; εS 300nm = 7210 M−1 cm−1 and εS 390nm = 67 M−1 cm−1; εEP 300nm = 5568 M−1 cm−1 and εEP 390nm = 86 M−1 cm−1; and εP 300nm = 630 M−1 cm−1 and εP 390nm = 40 M−1 cm−1. The molar extinction coefficients employed for bi-Co(II)-NDM-1 were: εE 412nm = 409 M−1 cm−1, εE 567nm = 295 M−1 cm−1 and εE 642nm = 239 M−1 cm−1; εS 412nm = 15 M−1 cm−1, εS 567nm = 0 M−1 cm−1 and εS 642nm = 0 M−1 cm−1; and εP 300nm = 630 M−1 cm−1, εP 567nm = 0 M−1 cm−1 and εP 642nm = 0 M−1 cm−1. εE, εS, and εP at different wavelengths were determined in each case by measuring the absorbance of different enzyme, substrate or product dilutions at the corresponding wavelength. Then, the molar extinction coefficients were determined by the linear fit of the Lambert-Beer law to absorbance vs. concentration plots. Product samples were obtained by hydrolysing known amounts of the substrate with catalytic concentrations of enzyme. The molar extinction coefficients of enzyme complexes were calculated as the addition of those corresponding to the species interacting in each case.

GOB-18 samples were quantified by using εE 280nm = 32,200 M−1 cm−1, while εE 280nm = 35,995 M−1 cm−1 was employed for mono-Zn(II)-Sfh-I, εE 280nm = 27,960 M−1 cm−1 for NDM-1 and εE 280nm = 30,500 M−1 cm−1 for bi-Zn(II)-BcII. Substrate samples were quantified by analysing the change in the absorbance at 300 nm due to complete hydrolysis by catalytic amounts of enzyme, and using Δε 300nm = –9000 M−1 cm−1 for imipenem and Δε 300nm = −6500 M−1 cm−1 for meropenem.

XAS experiments

For EXAFS studies, resting Sfh-I samples (~1 mM) were supplemented with 20% v/v glycerol as a glassing agent. Product samples were prepared by incubating 0.5 mM Sfh-I with 0.5 mM imipenem, supplemented with 20% (v/v) glycerol, for one hour on ice. EXAFS samples were loaded in Lucite cuvettes with 6 µm polypropylene windows, flash-frozen and stored in liquid nitrogen. Freeze-quenched EXAFS samples were obtained using a modified Update Instruments (Madison, WI) rapid-freeze-quench (RFQ) system55. All enzyme and substrate starting concentrations were 1 mM, in 50 mM HEPES metal-free (with Chelex 100, Bio-Rad), pH 7.0, 20 % v/v glycerol. The Update Instrument syringes were driven by a ram connected to a PMI-Kollmorgen stepping motor (model 00D12F-02001-1), which was in turn driven by a model 715 Update Instruments ram controller. The syringes, mixer, and tubing were maintained at 2 °C, in a watertight bath. Immediately prior to sample collection, the nozzle, and the attached mixer for the shortest reaction times, were removed from the bath and placed 5 mm above the surface of 2-methylbutane, contained in a collecting funnel. 2-methylbutane was kept at −130 °C by a surrounding bath (Update Instruments) of liquid nitrogen. Samples were packed into home-designed EXAFS sample holders at −130 °C; excess 2-methylbutane was decanted. All samples were kept in liquid nitrogen until data collection. Calibration of the RFQ system was accomplished by comparing the development of a low-spin Fe(III) EPR signal and the disappearance of a high-spin Fe(III) EPR signal with the associated optical changes at 636 nm, monitored by stopped-flow spectrophotometry, upon mixing excess sodium azide with myoglobin. The shortest, total effective reaction time achieved with the RFQ system was 10 ms45.

EXAFS spectroscopy: a Si (111) double-crystal monochromator was used at the National Synchrotron Light Source (NSLS), beamline X3B, to measure X-ray absorption spectra, and a Ni mirror was used to accomplish harmonic rejection. Fluorescence excitation spectra for all samples were recorded with a 31-element solid-state Ge detector array. Samples were held at ca 15 K in a Displex cryostat. EXAFS data collection and reduction were performed according to published procedures55. Data were measured in duplicate, on two independently prepared samples, by measuring six scans for each sample. Equivalent fits were obtained for the two data sets. The experimental spectra presented are the averaged data sets (12 scans per sample). The data were converted from energy to k-space using E0 = 9680 eV.

The nonlinear least-squares engine of IFEFFIT was used to fit Fourier-filtered EXAFS data. IFEFFIT is open source software available from, which is distributed with SixPack; which is available free of charge from Fourier-filtered EXAFS data were fitted utilising theoretical amplitude and phase functions calculated with FEFF v.8.0056. The zinc–nitrogen and zinc–sulphur scale factors and the threshold energy, ΔE0, were held fixed in all fits to the data for BcII, GOB, and Sfh-I samples (Zn–N Sc = 0.78, Zn–S Sc = 0.91, ∆E0 = −21 eV, as described previously). First shell fits were first obtained for all reasonable coordination numbers, including mixed nitrogen/oxygen/sulphur ligation, allowing only for variation of the absorber-scattered distances, Ras, and Debye−Waller factors, σas2. Multiple scattering contributions from histidine ligands and metal–metal scattering were fitted according to published procedures55.

1H-NMR measurements and analysis

The products resulting from the hydrolysis of imipenem catalysed by mono-Zn(II)-GOB-18, mono-Zn(II)-Sfh-I, bi-Zn(II)-NDM-1 and HCl were monitored by 1H-NMR. A solution of 2 mg/ml imipenem in 100 mM sodium phosphate pH 7.0 at 100% D2O was incubated at 25 °C with 10 nM of enzyme or HCl until the complete hydrolysis of imipenem. A volume of 500 µl of the mix were placed in an NMR tube and the 1D NMR spectra were collected. All spectra were acquired on Bruker Avance 600 MHz spectrometer equipped with a TXI probe, at 25 °C, with accumulation of 64 scans. We used a sweep width of 10,204 Hz for 1D 1H-NMR experiments. The excitation sculpting scheme was used to achieve water suppression57; the water-selective 180 °C sine-shaped pulse was 2 ms long. The FID was collected in 32 K data points. Prior to Fourier transformation, a 1 Hz exponential line broadening function was applied. TopSpin 3.0 was used to process and analyse NMR spectra. Signals were assigned based on the work of Ratcliffe et al.39. The same scaling ratio was used to plot all spectra in a given series.

QM-MM calculations

For hybrid QM–MM calculations58, the QM subsystem was treated at the density functional level using the programme SIESTA59. Basis sets of double-f plus polarisation quality were employed for all atoms, with a pseudoatomic orbital energy shift of 30 meV and a grid cutoff of 150 Ry. Basis sets of double zeta plus polarisation quality were employed for all atoms in the QM subsystem, and all calculations were performed using the generalized gradient approximation functional proposed by Perdew, Burke, and Ernzerhof (PBE)60. The Amber99 force field parametrization was used to treat the classical subsystem61.

The initial structures were taken from the experimental X-ray data: pdb code 4rbs and 4eyl32. Hydrogen atoms were added using Amber14 leap module62. Both Zn ions (with or without OH/water bridge) plus the coordinated side chains of residues His116, His118, Asp120, His196, Cys221, His263, and the hydrolysed meropenem modified in silico define the quantum subsystem, which comprises in total 82 atoms, also we added Lys224 in some calculations to study the effect of this residue. The rest of the protein and the water molecules ( ~ 23,500 atoms) were treated classically. The simulations were performed by assuming a pH value of 7.5. With the aim of generating the different species (EI1, EI2, EP1, and EP2), we modified in silico the quantum subsystem by adding or removing hydrogens atoms or water molecules. EI2 was obtained as we described above, then we added manually the H atom to C-2 to generate EP2. In the case of EI1 we used the initial structure of EI2 and we located a water molecule between the zinc ions, then we removed one of the protons of the water molecule and added it to the N atom of the hydrolysed substrate to obtain the initial structure of EP1. This method has been successfully applied for the study of metallo-proteins63,64,65.

Molecular dynamics simulations

The simulation was performed with Amber14 package62, starting from the crystal structure of NDM-1 bound to hydrolysed meropenem. The system was immersed in a truncated octahedral periodic box with a minimum solute-wall distance of 8 Å, filled with explicit TIP3P water molecules66. Ewald sums for treating long-range electrostatic interactions67. The SHAKE algorithm was applied to all hydrogen-containing bonds68. We used the ff99SB force field implemented in Amber14 to describe the protein. The force field of the active site (Zn, -OH, Asp, Cys, and His) was taken from the literature69. The charges and parameters of the hydrolysed substrate were determined using ab initio methods. The van der Waals radius, force constants and equilibrium distances, angles and dihedral were taken from gaff database62. Partial charges were RESP charges computed using Hartree–Fock method and 6-31 G* basis set70. The temperature and pressure were controlled by the Berendsen thermostat and barostat, respectively, as implemented in Amber1462. Cutoff values used for the van der Waals interactions were 10 Å. The system was equilibrated at 300 K using a conventional protocol49 and then subjected to 10 ns of simulation in the NVT ensemble. We applied a restraint to keep the hydrolysed meropenem bound to the active site.

Data availability

Supporting data are available from the corresponding authors upon reasonable request.

Additional Information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.

    Papp-Wallace, K. M., Endimiani, A., Taracila, M. A. & Bonomo, R. A. Carbapenems: past, present, and future. Antimicrob. Agents Chemother. 55, 4943–4960 (2011).

  2. 2.

    McKenna, M. Antibiotic resistance: the last resort. Nature 499, 394–396 (2013).

  3. 3.

    King, D. T., Sobhanifar, S. & Strynadka, N. C. One ring to rule them all: current trends in combating bacterial resistance to the beta-lactams. Protein Sci. 25, 787–803 (2016).

  4. 4.

    Llarrull, L. I., Testero, S. A., Fisher, J. F. & Mobashery, S. The future of the beta-lactams. Curr. Opin. Microbiol. 13, 551–557 (2010).

  5. 5.

    Fisher, J. F., Meroueh, S. O. & Mobashery, S. Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity. Chem. Rev. 105, 395–424 (2005).

  6. 6.

    Munoz-Price, L. S. et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect. Dis. 13, 785–796 (2013).

  7. 7.

    Crowder, M. W., Spencer, J. & Vila, A. J. Metallo-beta-lactamases: novel weaponry for antibiotic resistance in bacteria. Acc. Chem. Res. 39, 721–728 (2006).

  8. 8.

    Walsh, T. R., Toleman, M. A., Poirel, L. & Nordmann, P. Metallo-beta-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18, 306–325 (2005).

  9. 9.

    Mojica, M. F., Bonomo, R. A. & Fast, W. B1-Metallo-beta-Lactamases: Where Do We Stand? Curr. Drug Targets 17, 1029–1050 (2016).

  10. 10.

    Meini, M. R., Llarrull, L. I. & Vila, A. J. Overcoming differences: the catalytic mechanism of metallo-beta-lactamases. FEBS Lett. 589, 3419–3432 (2015).

  11. 11.

    Kumarasamy, K. K. et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10, 597–602 (2010).

  12. 12.

    Walsh, T. R., Weeks, J., Livermore, D. M. & Toleman, M. A. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11, 355–362 (2011).

  13. 13.

    Orellano, E. G., Girardini, J. E., Cricco, J. A., Ceccarelli, E. A. & Vila, A. J. Spectroscopic characterization of a binuclear metal site in Bacillus cereus beta-lactamase II. Biochemistry 37, 10173–10180 (1998).

  14. 14.

    King, D. & Strynadka, N. Crystal structure of New Delhi metallo-beta-lactamase reveals molecular basis for antibiotic resistance. Protein Sci. 20, 1484–1491 (2011).

  15. 15.

    Ullah, J. H. et al. The crystal structure of the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia at 1.7 A resolution. J. Mol. Biol. 284, 125–136 (1998).

  16. 16.

    Moran-Barrio, J. et al. Crystal structure of the metallo-beta-lactamase GOB in the periplasmic dizinc form reveals an unusual metal site. Antimicrob. Agents Chemother. 60, 6013–6022 (2016).

  17. 17.

    Fonseca, F., Bromley, E. H., Saavedra, M. J., Correia, A. & Spencer, J. Crystal structure of Serratia fonticola Sfh-I: activation of the nucleophile in mono-zinc metallo-beta-lactamases. J. Mol. Biol. 411, 951–959 (2011).

  18. 18.

    Garau, G. et al. A metallo-β-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem. J. Mol. Biol. 345, 785–795 (2005).

  19. 19.

    Moran-Barrio, J. et al. The metallo-beta-lactamase GOB is a mono-Zn(II) enzyme with a novel active site. J. Biol. Chem. 282, 18286–18293 (2007).

  20. 20.

    Hu, Z., Gunasekera, T. S., Spadafora, L., Bennett, B. & Crowder, M. W. Metal content of metallo-beta-lactamase L1 is determined by the bioavailability of metal ions. Biochemistry 47, 7947–7953 (2008).

  21. 21.

    Paul-Soto, R. et al. Mono- and binuclear Zn-beta-lactamase from Bacteroides fragilis: catalytic and structural roles of the zinc ions. FEBS Lett. 438, 137–140 (1998).

  22. 22.

    Badarau, A. & Page, M. I. Enzyme deactivation due to metal-ion dissociation during turnover of the cobalt-beta-lactamase catalyzed hydrolysis of beta-lactams. Biochemistry 45, 11012–11020 (2006).

  23. 23.

    Gonzalez, J. M. et al. Metallo-beta-lactamases withstand low Zn(II) conditions by tuning metal-ligand interactions. Nat. Chem. Biol. 8, 698–700 (2012).

  24. 24.

    Bounaga, S., Laws, A. P., Galleni, M. & Page, M. I. The mechanism of catalysis and the inhibition of the Bacillus cereus zinc-dependent beta-lactamase. Biochem. J. 331, 703–711 (1998).

  25. 25.

    Wang, Z., Fast, W. & Benkovic, S. J. On the mechanism of the metallo-beta-lactamase from Bacteroides fragilis. Biochemistry 38, 10013–10023 (1999).

  26. 26.

    Rasia, R. M. & Vila, A. J. Structural determinants of substrate binding to Bacillus cereus metallo-beta-lactamase. J. Biol. Chem. 279, 26046–26051 (2004).

  27. 27.

    Spencer, J., Clarke, A. R. & Walsh, T. R. Novel mechanism of hydrolysis of therapeutic beta-lactams by Stenotrophomonas maltophilia L1 metallo-beta-lactamase. J. Biol. Chem. 276, 33638–33644 (2001).

  28. 28.

    Tioni, M. F. et al. Trapping and characterization of a reaction intermediate in carbapenem hydrolysis by B. cereus metallo-beta-lactamase. J. Am. Chem. Soc. 130, 15852–15863 (2008).

  29. 29.

    Wang, Z., Fast, W. & Benkovic, S. J. Direct observation of an enzyme-bound intermediate in the catalytic cycle of the metallo-β-lactamase from bacteroides fragilis. J. Am. Chem. Soc. 120, 10788–10789 (1998).

  30. 30.

    Feng, H. et al. Structural and mechanistic insights into NDM-1 catalyzed hydrolysis of cephalosporins. J. Am. Chem. Soc. 136, 14694–14697 (2014).

  31. 31.

    Hawk, M. J. et al. Differential binding of Co(II) and Zn(II) to metallo-beta-lactamase Bla2 from Bacillus anthracis. J. Am. Chem. Soc. 131, 10753–10762 (2009).

  32. 32.

    King, D. T., Worrall, L. J., Gruninger, R. & Strynadka, N. C. New Delhi metallo-beta-lactamase: structural insights into beta-lactam recognition and inhibition. J. Am. Chem. Soc. 134, 11362–11365 (2012).

  33. 33.

    Kim, Y. et al. NDM-1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism. FASEB J. 27, 1917–1927 (2013).

  34. 34.

    Wachino, J. et al. Structural insights into recognition of hydrolyzed carbapenems and inhibitors by subclass B3 metallo-beta-lactamase SMB-1. Antimicrob. Agents Chemother. 60, 4274–4282 (2016).

  35. 35.

    Lisa, M. N., Hemmingsen, L. & Vila, A. J. Catalytic role of the metal ion in the metallo-beta-lactamase GOB. J. Biol. Chem. 285, 4570–4577 (2010).

  36. 36.

    Bertini, I. & Luchinat, C. High spin cobalt(II) as a probe for the investigation of metalloproteins. Adv. Inorg. Biochem. 6, 71–111 (1984).

  37. 37.

    Yang, H. et al. Spectroscopic and mechanistic studies of heterodimetallic forms of metallo-beta-lactamase NDM-1. J. Am. Chem. Soc. 136, 7273–7285 (2014).

  38. 38.

    Breece, R. M., Llarrull, L. I., Tioni, M. F., Vila, A. J. & Tierney, D. L. X-ray absorption spectroscopy of metal site speciation in the metallo-beta-lactamase BcII from Bacillus cereus. J. Inorg. Biochem. 111, 182–186 (2012).

  39. 39.

    Ratcliffe, R. W. et al. Studies on the structures of imipenem, dehydropeptidase I-hydrolyzed imipenem, and related analogs. J. Org. Chem. 54, 653–660 (1989).

  40. 40.

    Schenk, G. et al. Binuclear metallohydrolases: complex mechanistic strategies for a simple chemical reaction. Acc. Chem. Res. 45, 1593–1603 (2012).

  41. 41.

    Llarrull, L. I., Tioni, M. F. & Vila, A. J. Metal content and localization during turnover in B. cereus metallo-beta-lactamase. J. Am. Chem. Soc. 130, 15842–15851 (2008).

  42. 42.

    Brem, J. et al. Studying the active-site loop movement of the Sao Paolo metallo-beta-lactamase-1. Chem. Sci. 6, 956–963 (2015).

  43. 43.

    Oelschlaeger, P. et al. Meropenem and chromacef intermediates observed in IMP-25 metallo-beta-lactamase-catalyzed hydrolysis. Antimicrob. Agents Chemother. 59, 4326–4330 (2015).

  44. 44.

    Breece, R. M., Hu, Z., Bennett, B., Crowder, M. W. & Tierney, D. L. Motion of the zinc ions in catalysis by a dizinc metallo-beta-lactamase. J. Am. Chem. Soc. 131, 11642–11643 (2009).

  45. 45.

    Garrity, J. D., Bennett, B. & Crowder, M. W. Direct evidence that the reaction intermediate of metallo-beta-lactamase L1 is metal bound. Biochemistry 44, 1078–1087 (2005).

  46. 46.

    Selleck, C. et al. AIM-1: an antibiotic-degrading metallohydrolase that displays mechanistic flexibility. Chemistry 22, 17704–17714 (2016).

  47. 47.

    Das, C. K. & Nair, N. N. Hydrolysis of cephalexin and meropenem by New Delhi metallo-beta-lactamase: the substrate protonation mechanism is drug dependent. Phys. Chem. Chem. Phys. 19, 13111–13121 (2017).

  48. 48.

    Hu, Z., Periyannan, G., Bennett, B. & Crowder, M. W. Role of the Zn1 and Zn2 sites in metallo-beta-lactamase L1. J. Am. Chem. Soc. 130, 14207–14216 (2008).

  49. 49.

    Gonzalez, L. J., Moreno, D. M., Bonomo, R. A. & Vila, A. J. Host-specific enzyme-substrate interactions in SPM-1 metallo-beta-lactamase are modulated by second sphere residues. PLoS Pathog. 10, e1003817 (2014).

  50. 50.

    Meini, M. R., Tomatis, P. E., Weinreich, D. M. & Vila, A. J. Quantitative description of a protein fitness landscape based on molecular features. Mol. Biol. Evol. 32, 1774–1787 (2015).

  51. 51.

    Gonzalez, M. M. et al. Bisthiazolidines: a substrate-mimicking scaffold as an inhibitor of the NDM-1 carbapenemase. ACS Infect. Dis. 1, 544–554 (2015).

  52. 52.

    Hinchliffe, P. et al. Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes. Proc. Natl Acad. Sci. 113, E3745–E3754 (2016).

  53. 53.

    Llarrull, L. I., Tioni, M. F., Kowalski, J., Bennett, B. & Vila, A. J. Evidence for a dinuclear active site in the metallo-beta-lactamase BcII with substoichiometric Co(II). A new model for metal uptake. J. Biol. Chem. 282, 30586–30595 (2007).

  54. 54.

    Kuzmic, P. Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase. Anal. Biochem. 237, 260–273 (1996).

  55. 55.

    Tierney, D. L. & Schenk, G. X-ray absorption spectroscopy of dinuclear metallohydrolases. Biophys. J. 107, 1263–1272 (2014).

  56. 56.

    Ankudinov, A. L., Ravel, B., Rehr, J. J. & Conradson, S. D. Real-space multiple-scattering calculation and interpretation of x-ray-absorption near-edge structure. Phys. Rev. B 58, 7565–7576 (1998).

  57. 57.

    Hwang, T. L. & Shaka, A. J. Water suppression that works. excitation sculpting using arbitrary waveforms and pulsed field gradients. J. Magn. Reson. 112, 275–279 (1995).

  58. 58.

    Crespo, A. et al. A DFT-based QM-MM approach designed for the treatment of large molecular systems: application to chorismate mutase. J. Phys. Chem. B. 107, 13728–13736 (2003).

  59. 59.

    Soler, J. M. et al. The SIESTA method for ab initio order- N materials simulation. J. Phys: Condens. Matter 14, 2745 (2002).

  60. 60.

    Perdew, J. P., Burke, K. & Ernzerhof, M. Generalized gradient approximation made simple. Phys. Rev. Lett. 77, 3865–3868 (1996).

  61. 61.

    Wang, J., Cieplak, P. & Kollman, P. A. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J. Comput. Chem. 21, 1049–1074 (2000).

  62. 62.

    Case, D. A. et al. AMBER 14, (University of California, 2014).

  63. 63.

    Rudzka, K. et al. Coordination of peroxide to the Cu(M) center of peptidylglycine α-hydroxylating monooxygenase (PHM): structural and computational study. J. Biol. Inorg. Chem. 18, 223–232 (2013).

  64. 64.

    Crespo, A., Martí, M. A., Roitberg, A. E., Amzel, L. M. & Estrin, D. A. The catalytic mechanism of peptidylglycine α-hydroxylating monooxygenase investigated by computer simulation. J. Am. Chem. Soc. 128, 12817–12828 (2006).

  65. 65.

    Martí, M. A., Capece, L., Crespo, A., Doctorovich, F. & Estrin, D. A. Nitric oxide interaction with cytochrome c ‘and its relevance to guanylate cyclase. Why does the iron histidine bond break? J. Am. Chem. Soc. 127, 7721–7728 (2005).

  66. 66.

    Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926–935 (1983).

  67. 67.

    Luty, B. A., Tironi, I. G. & van Gunsteren, W. F. Lattice‐sum methods for calculating electrostatic interactions in molecular simulations. J. Chem. Phys. 103, 3014–3021 (1995).

  68. 68.

    Ahlrichs, R. & Brode, S. A new rigid motion algorithm for MD simulations. Comput. Phys. Commun. 42, 59–64 (1986).

  69. 69.

    Suárez, D., Brothers, E. N. & Merz, K. M. Insights into the structure and dynamics of the dinuclear zinc β-lactamase site from bacteroides fragilis. Biochemistry 41, 6615–6630 (2002).

  70. 70.

    Bayly, C. I., Cieplak, P., Cornell, W. & Kollman, P. A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. J. Phys. Chem. 97, 10269–10280 (1993).

Download references


M.-N.L., A.R.P., and M.M.G. were recipients of doctoral fellowships from CONICET. A.J.V., D.M.M., and L.I.L. are staff members from CONICET. This work was supported by grants from ANPCyT and NIH (R01 AI100560-01) to A.J.V., and from NIH (GM093987) and the National Science Foundation (CHE-1151658) to M.W.C. and D.L.T.; We also acknowledge P30-EB-009998 to the Center for Synchrotron Biosciences from the NIBIB, which supports beamline X3B at the NSLS.

Author information

Author notes

    • María-Natalia Lisa

    Present address: Laboratory of Molecular and Structural Microbiology, Institut Pasteur de Montevideo, Montevideo, 11400, Uruguay

  1. María-Natalia Lisa and Antonela R. Palacios contributed equally to this work.


  1. Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Ocampo y Esmeralda, S2002LRK, Rosario, Argentina

    • María-Natalia Lisa
    • , Antonela R. Palacios
    • , Mariano M. González
    • , Leticia I. Llarrull
    •  & Alejandro J. Vila
  2. Department of Chemistry and Biochemistry, Miami University, 651 E. High St., Oxford, OH, 45056, USA

    • Mahesh Aitha
    • , Michael W. Crowder
    •  & David L. Tierney
  3. Instituto de Química Rosario (IQUIR, CONICET-UNR), Suipacha 531, Rosario, S2002LRK, Argentina

    • Diego M. Moreno
  4. Área Química General e Inorgánica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, S2002LRK, Rosario, Argentina

    • Diego M. Moreno
  5. Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106, USA

    • Robert A. Bonomo
  6. Departments of Medicine, Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA

    • Robert A. Bonomo
  7. CARES, CWRU-VA Center for Antibiotic Resistance and Epidemiology, Cleveland, OH 44106, USA

    • Robert A. Bonomo
    •  & Alejandro J. Vila
  8. School of Cellular and Molecular Medicine, University of Bristol Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, UK

    • James Spencer
  9. Area Biofísica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, S2002LRK, Rosario, Argentina

    • Leticia I. Llarrull
    •  & Alejandro J. Vila


  1. Search for María-Natalia Lisa in:

  2. Search for Antonela R. Palacios in:

  3. Search for Mahesh Aitha in:

  4. Search for Mariano M. González in:

  5. Search for Diego M. Moreno in:

  6. Search for Michael W. Crowder in:

  7. Search for Robert A. Bonomo in:

  8. Search for James Spencer in:

  9. Search for David L. Tierney in:

  10. Search for Leticia I. Llarrull in:

  11. Search for Alejandro J. Vila in:


M.-N.L. and A.R.P. purified protein samples, performed and analysed the stopped-flow experiments. M.M.G. purified protein samples and ran the NMR spectra. D.M.M. performed the QM-MM and MD calculations. M.A., M.W.C., and D.L.T. ran and interpreted the XAS experiments. M.-N.L., A.R.P., D.L.T., R.A.B., J.S., L.I.L., and A.J.V. analysed and discussed data. M.-N.L., A.R.P., L.I.L., and A.J.V. wrote the paper, and all authors discussed the results and commented on the manuscript.

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Leticia I. Llarrull or Alejandro J. Vila.

Electronic supplementary material


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Creative Commons BY

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit